Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.38%.

  • Abeona Therapeutics' Return on Capital Employed rose 1700.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.92% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Return on Capital Employed is 0.38%, which was up 1700.0% from 0.54% recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Return on Capital Employed ranged from a high of 0.38% in Q3 2025 and a low of 2.9% during Q3 2022
  • For the 5-year period, Abeona Therapeutics' Return on Capital Employed averaged around 1.0%, with its median value being 0.82% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -23200bps in 2022, then soared by 19900bps in 2023.
  • Over the past 5 years, Abeona Therapeutics' Return on Capital Employed (Quarter) stood at 1.09% in 2021, then decreased by -7bps to 1.16% in 2022, then grew by 22bps to 0.91% in 2023, then grew by 28bps to 0.65% in 2024, then surged by 41bps to 0.38% in 2025.
  • Its Return on Capital Employed stands at 0.38% for Q3 2025, versus 0.54% for Q2 2025 and 0.81% for Q1 2025.